Surgical Science Sweden AB (publ) (STO:SUS)
Sweden
· Delayed Price · Currency is SEK 31.44
-0.60 (-1.87%)
At close: Mar 9, 2026
STO:SUS Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,604 | 1,658 | 7,955 | 9,312 | 8,367 | 14,301 | Upgrade
|
| Market Cap Growth | -80.45% | -79.15% | -14.57% | 11.30% | -41.49% | 343.39% | Upgrade
|
| Enterprise Value | 989 | 1,063 | 7,289 | 8,706 | 7,997 | 13,990 | Upgrade
|
| Last Close Price | 31.44 | 32.50 | 155.90 | 182.50 | 164.70 | 281.50 | Upgrade
|
| PE Ratio | 24.01 | 24.82 | 60.43 | 39.80 | 44.51 | 165.81 | Upgrade
|
| Forward PE | 14.03 | 14.63 | 34.77 | 40.02 | 54.94 | 157.93 | Upgrade
|
| PS Ratio | 1.62 | 1.67 | 9.00 | 10.55 | 10.43 | 38.99 | Upgrade
|
| PB Ratio | 0.38 | 0.39 | 1.65 | 2.14 | 1.98 | 3.99 | Upgrade
|
| P/TBV Ratio | 1.79 | 1.85 | 8.83 | 12.76 | 17.04 | 49.01 | Upgrade
|
| P/FCF Ratio | 23.55 | 24.35 | 60.67 | 40.87 | 69.65 | 406.13 | Upgrade
|
| P/OCF Ratio | 20.10 | 20.78 | 57.97 | 39.08 | 64.62 | 365.90 | Upgrade
|
| PEG Ratio | - | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 | Upgrade
|
| EV/Sales Ratio | 1.00 | 1.07 | 8.24 | 9.86 | 9.96 | 38.14 | Upgrade
|
| EV/EBITDA Ratio | 4.54 | 5.46 | 42.96 | 41.04 | 45.06 | 141.31 | Upgrade
|
| EV/EBIT Ratio | 7.36 | 7.90 | 50.50 | 46.03 | 50.98 | 168.60 | Upgrade
|
| EV/FCF Ratio | 14.53 | 15.60 | 55.59 | 38.21 | 66.57 | 397.31 | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | 0.01 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.31 | 0.18 | 0.08 | 0.11 | Upgrade
|
| Debt / FCF Ratio | 0.02 | 0.02 | 0.43 | 0.18 | 0.12 | 0.34 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.14 | -0.19 | -0.14 | -0.10 | -0.08 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.16 | -3.16 | -5.37 | -2.80 | -2.36 | -3.08 | Upgrade
|
| Net Debt / FCF Ratio | -9.03 | -9.03 | -6.95 | -2.61 | -3.49 | -8.65 | Upgrade
|
| Asset Turnover | 0.20 | 0.20 | 0.17 | 0.19 | 0.19 | 0.17 | Upgrade
|
| Inventory Turnover | 1.74 | 1.74 | 1.71 | 1.87 | 2.19 | 1.61 | Upgrade
|
| Quick Ratio | 2.83 | 2.83 | 2.39 | 3.52 | 2.22 | 2.14 | Upgrade
|
| Current Ratio | 4.07 | 4.07 | 2.78 | 4.22 | 2.70 | 2.66 | Upgrade
|
| Return on Equity (ROE) | 1.47% | 1.47% | 2.87% | 5.45% | 4.81% | 4.30% | Upgrade
|
| Return on Assets (ROA) | 1.65% | 1.65% | 1.77% | 2.53% | 2.27% | 2.33% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.44% | 2.37% | 3.13% | 4.36% | 3.99% | 4.58% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.10% | 3.10% | 2.90% | 4.20% | 3.60% | 2.20% | Upgrade
|
| Earnings Yield | 4.17% | 4.03% | 1.65% | 2.51% | 2.25% | 0.60% | Upgrade
|
| FCF Yield | 4.25% | 4.11% | 1.65% | 2.45% | 1.44% | 0.25% | Upgrade
|
| Buyback Yield / Dilution | - | - | -0.17% | -0.05% | -19.32% | -24.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.